Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Up Front MattersEditorials
You have accessRestricted Access

Innate Immunity and Dendritic Cells in Kidney Disease and the Nobel Prize

Hans-Joachim Anders and Christian Kurts
JASN December 2011, 22 (12) 2139-2141; DOI: https://doi.org/10.1681/ASN.2011100975
Hans-Joachim Anders
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Kurts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading

On December 10, 2011, the Nobel Prize for Physiology or Medicine will honor the work of Jules Hoffmann, Bruce Beutler, and Ralph Steinman for their landmark discoveries in the field of immunology. This recognition brings wide attention to a paradigm shift in understanding how multicellular organisms sense and interpret their external and internal environments in maintaining homeostasis or initiating host defense in case of pathogen danger and infection.1,2 Unraveling these fundamental processes not only allowed a better understanding of how pathology develops but also offered novel possibilities for disease prevention and cure, including kidney diseases.

It was the previous Nobel laureate, Christiane Nüsslein-Volhard, that unexpectedly set the stage for a piece of this year's award. Nüsslein-Volhard had induced random mutagenesis in Drosophila to search for unknown genotype-phenotype associations. In 1984, one such mutant attracted her attention so much that she shouted the German word Toll, meaning “great.” Obviously, her joy encouraged her postdoctoral fellows to name the mutated gene as such. During the following decade, a few papers were published on the role of Toll for dorsal-ventral polarity of flies. This changed dramatically when Jules Hoffmann's group in Strasbourg reported in 1996 that Toll-deficient flies succumb to fungal infection, which established a role for Toll in host defense.3 One year later, the Janeway Laboratory at Yale described the human homologue Toll-like receptor (TLR) genes.4 Unfortunately, Janeway died in 2003 and was no longer eligible to receive the prize.

The discoveries of Hoffmann and Janeway alerted immunologists all over the world to the possibility of a new signaling pathway, and in 1998, Bruce Beutler and colleagues at the Howard Hughes Medical Institute in Dallas first identified TLR4 as recognizing bacterial endotoxin.5 Beutler's approach was as clever as simple. He took advantage of two well-known lipopolysaccharide-resistant mouse strains to map the newly discovered loci of the Toll genes. In doing so, he realized that endotoxin resistance was linked to loss-of-function mutations in the Tlr4 gene.

Two more circumstances encouraged researchers from many disciplines to rush into this new area of science, producing more than 18,000 related publications within the last 15 years: first, Tlr4 mutant mice as well as suitable immunostimulatory compounds, now discovered as agonists for distinct TLRs, became available at relatively low costs to everyone, and second, Shizou Akira, in Osaka, produced null mice for most TLRs and many other related genes, and did not hesitate to share them with collaborators and competitors. His generous attitude enormously pushed the field forward in short time.6 But what has this all to do with the kidney?

The kidney is a sterile organ but well equipped with TLRs and other innate pattern recognition receptors ready to signal danger upon the entry of pathogens. For example, in infective pyelonephritis, ascending uropathogenic Escherichia coli provide endotoxin from their bacterial wall to engage TLR4 on tubular epithelial cells and intrarenal dendritic cells, a process triggering the release of cytokines and chemokines leading to renal inflammation involving the rapid recruitment of neutrophils into the kidney and the tubular lumen noted on urinalysis. Tlr4 mutant mice cannot recognize bacterial endotoxin inside the kidney; hence, uropathogenic E. coli no longer induce chemokines and neutrophil recruitment.7 Insufficient immune recognition, however, is Janus-faced, and failing local pathogen control allows potentially fatal systemic spreading through immunodeficiency reminiscent of urosepsis. On the other hand, lack of TLR4 prevents immunopathology such as renal abscesses in E. coli pyelonephritis.

Meanwhile, it is clear that TLRs more than guard against pathogens as a potential source of danger in tissue homeostasis. Dying cells in that environment release intracellular factors with comparable potential to trigger local inflammation through TLRs.8 This means innate immunity not only signals pathogen entry but also monitors tissue integrity, which can be disrupted by any type of injury. Thus, renal cell necrosis involves additional immunopathology by activating innate immunity. Numerous studies now document that too much TLR signaling causes additional renal damage in acute kidney injury and that blocking TLR signaling protects kidneys from inappropriate immunopathology.8 This amplification of injury not only involves TLRs; RIG-like helicases, the inflammasome, small leucine–rich proteoglycans, and lectin receptors add to the complexity of innate pattern recognition.9–11

The other half of the 2011 Nobel Prize was awarded to the late Ralph Steinman, for his discovery of dendritic cells and their unique capacity to activate and regulate adaptive immunity.12,13 Dendritic cells are not immune effectors themselves; they instruct other immune cells, especially T lymphocytes. To this end, dendritic cells exist in virtually all tissues as immune sentinels. Once they sense pathogens using pattern receptors like TLR, they become activated and gather and carry suspicious antigenic material to lymph nodes to activate T lymphocytes,14 another immune cell type originally identified by Jacques Miller in the early 1960s.15 These T cells in turn become activated to perform various immune responses, such as cytotoxicity, delayed-type hypersensitivity, or stimulating B lymphocytes to produce antibodies.

Lymphocytes do not simply calm down after performing their immune engagement. Some of them persist as so-called memory cells, which are capable of faster, stronger, and more specific responses, such as when pathogens reinfect an organism. Such immunologic memory is the basis of all vaccinations and of immunity in its original meaning. After the Nobel committee in 1996 had honored the complicated mechanism by which T cells are activated by dendritic cells, so-called MHC restriction,16 this year's prize pays tribute to the immune cells that engage this mechanism, and their discoverer.

Ralph Steinman discovered dendritic cells in 1973 as a postdoctoral fellow with Zanvil Cohn at the Rockefeller University. Dendritic cells are characterized by numerous branched projections, the dendrites from the Greek word, Dendron, meaning tree. He described these cells as motile, continuously extending, retracting, and reorienting their dendritic processes, but comparatively poor in endocytosis.17 Before the discovery of MHC restriction, this functionality appeared bewildering, and it took a long time to appreciate its exquisite suitability for T cell activation. Dendritic cells use small amounts of captured antigen extremely efficiently for T cell activation, taking advantage of unique intracellular mechanisms such as cross-presentation.18 In addition to antigens from pathogens, dendritic cells also present self-antigens. The latter antigens normally engage autoreactive T cells, which otherwise would lead to autoimmunity, but instead induces their apoptosis. In other words, dendritic cells (DCs) also maintain homeostasis by preventing autoimmunity;19 their failure to tolerize autoreactive T cells is a critical factor in autoimmunity.18 Thus, DCs can be considered the maestro of adaptive immunity.

DCs also heavily affect renal disease, although this was realized much later than in other disciplines, and consequently, the field of dendritic cells in the kidney has lagged somewhat behind.20 Initial descriptions of renal tubulointerstitial cells with morphologic characteristics of dendritic cells date back to the early 1990s,21 but studies of their functional roles were only initiated about 10 years ago.20 Since then, it has become clear that kidney dendritic cells act as sentinels against injury after renal obstruction or ischemia/reperfusion,22 in that they suppress unwanted intrarenal immune responses. However, in chronic kidney inflammation, they mature and drive progression of renal disease.23 Notably, they also orchestrate innate defenses against bacterial pyelonephritis by recruiting neutrophils into the kidney.24 The potential of kidney dendritic cells to affect renal inflammation makes them highly promising therapeutic candidates.

Only a few hours before the Nobel committee decided to award the prize to him, Ralph Steinman lost his long battle to cancer, a cancer that was treated successfully for 4 years using immunization protocols that depend on dendritic cell function. Although the Nobel Prize is not awarded posthumously, exceptions can be made, and the committee decided to do so in this special case. The president of the British Royal Society, Sir Paul Nurse—himself a Nobel laureate—commented: “This is a great tragedy. Ralph Steinman's work was ahead of its time and he waited too long for the Nobel Prize. To die just days before its announcement is almost too much to bear. He will be remembered as one of the great immunologists of our time.” Jules Hoffman, Bruce Beutler, and Ralph Steinman were awarded the Nobel Prize 2011 because their discoveries advance our understanding of immunopathology. It remains our task to bring this to the benefit of patients with kidney disease.

DISCLOSURES

None.

Acknowledgments

H.J.A. is supported by grants from the Deutsche Forschungsgemeinschaft (AN372/9-2, 10-1, 14-1, and GRK 1202). C.K. is supported by grants from the Deutsche Forschungsgemeinschaft (KFO228, SFB TR57, SFB704, SFB645) and by the EU Consortium Intricate.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • Copyright © 2011 by the American Society of Nephrology

REFERENCES

  1. 1.↵
    1. Matzinger P
    : The danger model: A renewed sense of self. Science 296: 301–305, 2002
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Medzhitov R
    : Origin and physiological roles of inflammation. Nature 454: 428–435, 2008
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Lemaitre B,
    2. Nicolas E,
    3. Michaut L,
    4. Reichhart JM,
    5. Hoffmann JA
    : The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973–983, 1996
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Medzhitov R,
    2. Preston-Hurlburt P,
    3. Janeway CA Jr..
    : A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394–397, 1997
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Poltorak A,
    2. He X,
    3. Smirnova I,
    4. Liu MY,
    5. Van Huffel C,
    6. Du X,
    7. Birdwell D,
    8. Alejos E,
    9. Silva M,
    10. Galanos C,
    11. Freudenberg M,
    12. Ricciardi-Castagnoli P,
    13. Layton B,
    14. Beutler B
    : Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282: 2085–2088, 1998
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Takeuchi O,
    2. Akira S
    : Pattern recognition receptors and inflammation. Cell 140: 805–820, 2010
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Patole PS,
    2. Schubert S,
    3. Hildinger K,
    4. Khandoga S,
    5. Khandoga A,
    6. Segerer S,
    7. Henger A,
    8. Kretzler M,
    9. Werner M,
    10. Krombach F,
    11. Schlondorff D,
    12. Anders HJ
    : Toll-like receptor-4: Renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 68: 2582–2587, 2005
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Anders HJ
    : Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 21: 1270–1274, 2010
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Schaefer L
    : Small leucine-rich proteoglycans in kidney disease. J Am Soc Nephrol 22: 1200–1207, 2011
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Anders HJ,
    2. Muruve DA
    : The inflammasomes in kidney disease. J Am Soc Nephrol 22: 1007–1018, 2011
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Rosin DL,
    2. Okusa MD
    : Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22: 416–425, 2011
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Steinman RM,
    2. Banchereau J
    : Taking dendritic cells into medicine. Nature 449: 419–426, 2007
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Steinman RM,
    2. Mellman I
    : Immunotherapy: Bewitched, bothered, and bewildered no more. Science 305: 197–200, 2004
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Banchereau J,
    2. Steinman RM
    : Dendritic cells and the control of immunity. Nature 392: 245–252, 1998
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Miller JF
    : The golden anniversary of the thymus. Nat Rev Immunol 11: 489–495, 2011
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Zinkernagel RM,
    2. Doherty PC
    : The discovery of MHC restriction. Immunol Today 18: 14–17, 1997
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Steinman RM,
    2. Cohn ZA
    : Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137: 1142–1162, 1973
    OpenUrlAbstract
  18. 18.↵
    1. Kurts C,
    2. Robinson BW,
    3. Knolle PA
    : Cross-priming in health and disease. Nat Rev Immunol 10: 403–414, 2010
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Steinman RM,
    2. Hawiger D,
    3. Nussenzweig MC
    : Tolerogenic dendritic cells. Annu Rev Immunol 21: 685–711, 2003
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. John R,
    2. Nelson PJ
    : Dendritic cells in the kidney. J Am Soc Nephrol 18: 2628–2635, 2007
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Kaissling B,
    2. Hegyi I,
    3. Loffing J,
    4. Le Hir M
    : Morphology of interstitial cells in the healthy kidney. Anat Embryol (Berl) 193: 303–318, 1996
    OpenUrlPubMed
  22. 22.↵
    1. Dong X,
    2. Swaminathan S,
    3. Bachman LA,
    4. Croatt AJ,
    5. Nath KA,
    6. Griffin MD
    : Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 71: 619–628, 2007
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Hochheiser K,
    2. Engel DR,
    3. Hammerich L,
    4. Heymann F,
    5. Knolle PA,
    6. Panzer U,
    7. Kurts C
    : Kidney dendritic cells become pathogenic during crescentic glomerulonephritis with proteinuria. J Am Soc Nephrol 22: 306–316, 2011
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Tittel AP,
    2. Heuser C,
    3. Ohliger C,
    4. Knolle PA,
    5. Engel DR,
    6. Kurts C
    : Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol 22: 1435–1441, 2011
    OpenUrlAbstract/FREE Full Text
  25. 25.
    1. Steinman RM
    : Dendritic cells in vivo: A key target for a new vaccine science. Immunity 29: 319–324, 2008
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 22 (12)
Journal of the American Society of Nephrology
Vol. 22, Issue 12
1 Dec 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Innate Immunity and Dendritic Cells in Kidney Disease and the Nobel Prize
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Innate Immunity and Dendritic Cells in Kidney Disease and the Nobel Prize
Hans-Joachim Anders, Christian Kurts
JASN Dec 2011, 22 (12) 2139-2141; DOI: 10.1681/ASN.2011100975

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Innate Immunity and Dendritic Cells in Kidney Disease and the Nobel Prize
Hans-Joachim Anders, Christian Kurts
JASN Dec 2011, 22 (12) 2139-2141; DOI: 10.1681/ASN.2011100975
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • DISCLOSURES
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • View PDF

More in this TOC Section

Up Front Matters

  • Me Or Your Own Eyes: RNA-Seq and the Kidney
  • Automated Quantification of Chronic Changes in the Kidney Biopsy: Another Step in the Right Direction
  • Passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act—a Chance to Celebrate and Reflect
Show more Up Front Matters

Editorials

  • Race and the Estimation of GFR: Getting it Right
  • Monkeying about with Nephron Formation
  • Kidney Transplant Rejection Clusters and Graft Outcomes: Revisiting Banff in the Era of “Big Data”
Show more Editorials

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire